Evolus, Inc. (EOLS)
7.79
-0.78
(-9.10%)
USD |
NASDAQ |
Sep 10, 13:09
Evolus Price : 7.79 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 8.85 | 9.05 | 8.51 | 8.57 | 996576.0 |
| Sep 08, 2026 | 9.00 | 9.12 | 8.751 | 8.88 | 1.728M |
| Sep 04, 2026 | 9.05 | 9.31 | 8.975 | 9.30 | 696365.0 |
| Sep 03, 2026 | 9.08 | 9.10 | 8.91 | 9.05 | 734417.0 |
| Sep 02, 2026 | 9.04 | 9.13 | 8.93 | 9.06 | 773979.0 |
| Sep 01, 2026 | 9.04 | 9.124 | 8.93 | 9.08 | 594023.0 |
| Aug 31, 2026 | 8.85 | 9.15 | 8.75 | 9.09 | 1.027M |
| Aug 28, 2026 | 8.84 | 8.94 | 8.595 | 8.88 | 1.059M |
| Aug 27, 2026 | 8.78 | 9.035 | 8.60 | 8.88 | 1.195M |
| Aug 26, 2026 | 8.86 | 9.08 | 8.77 | 8.78 | 1.514M |
| Aug 25, 2026 | 8.72 | 9.12 | 8.70 | 8.975 | 1.797M |
| Aug 24, 2026 | 8.39 | 8.82 | 8.260 | 8.78 | 1.320M |
| Aug 21, 2026 | 8.35 | 8.48 | 8.235 | 8.39 | 582721.0 |
| Aug 20, 2026 | 8.55 | 8.55 | 8.32 | 8.35 | 663321.0 |
| Aug 19, 2026 | 8.22 | 8.69 | 8.22 | 8.60 | 964004.0 |
| Aug 18, 2026 | 7.81 | 8.265 | 7.81 | 8.18 | 710440.0 |
| Aug 17, 2026 | 8.13 | 8.231 | 7.72 | 7.77 | 614480.0 |
| Aug 14, 2026 | 8.02 | 8.258 | 7.91 | 8.155 | 648719.0 |
| Aug 13, 2026 | 8.11 | 8.335 | 8.00 | 8.02 | 778375.0 |
| Aug 12, 2026 | 8.24 | 8.35 | 8.07 | 8.12 | 959132.0 |
| Aug 11, 2026 | 7.68 | 8.43 | 7.55 | 8.34 | 2.795M |
| Aug 10, 2026 | 7.465 | 7.64 | 7.18 | 7.57 | 1.396M |
| Aug 07, 2026 | 7.28 | 7.80 | 7.21 | 7.59 | 1.632M |
| Aug 06, 2026 | 6.99 | 7.52 | 6.54 | 7.41 | 2.920M |
| Aug 05, 2026 | 6.13 | 6.235 | 6.02 | 6.18 | 1.161M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 70.46 |
| Corcept Therapeutics, Inc. | 115.44 |
| Veru, Inc. | 2.51 |
| Johnson & Johnson | 266.51 |
| Eli Lilly & Co. | 1126.50 |
Price Related Metrics
| PS Ratio | 1.607 |
| Earnings Yield | -6.77% |
| Market Cap | 514.25M |